MedPath

Norethindrone Acetate and Ethinyl Estradiol

Norethindrone Acetate and Ethinyl Estradiol Tablets, USP 1 mg/ 0.02 mg Rx only

Approved
Approval ID

5a44f7a2-45f1-4d28-b9fb-61d9f2456422

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2023

Manufacturers
FDA

Glenmark Pharmaceuticals Inc., USA

DUNS: 130597813

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68462-132
Application NumberANDA206969
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate and Ethinyl Estradiol
Product Specifications
Route of AdministrationORAL
Effective DateJune 22, 2022
FDA Product Classification

INGREDIENTS (8)

NORETHINDRONE ACETATEActive
Quantity: 1 mg in 1 1
Code: 9S44LIC7OJ
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ETHINYL ESTRADIOLActive
Quantity: 0.02 mg in 1 1
Code: 423D2T571U
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norethindrone Acetate and Ethinyl Estradiol - FDA Drug Approval Details